High-throughput immunoproteomics for cancer biomarkers
Official title: High-throughput immunoproteomics for cancer biomarker discovery
Funded at Arizona State University-Tempe Campus · NIH-11412526 · Data updated 2026-11-12
A cancer biomarker discovery effort uses high-throughput immunoproteomics to help identify biological signals that could lead to better cancer diagnostics.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arizona State University-Tempe Campus NIH-funded |
| Lab location | 1 site (Scottsdale, United States) |
| Project start | September 1, 2022 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $286,293 |
| NIH project number | 5U2CCA271903-05 |
| Project ID | NIH-11412526 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable to a specific patient group in this core; the work informs cancer diagnostics broadly.
✕Less likely to help
There is no direct treatment or patient intervention in this administrative core.
What this research studies
This project focuses on identifying immune-related protein markers that signal cancer, using rapid, large-scale protein profiling. It is organized as an Administrative Core that coordinates research activities, budgeting, communication, and collaboration across sites. The goal is to share findings efficiently among researchers and with the wider community to speed progress toward better cancer diagnostics.
Why it matters
Potential benefit: If successful, patients could benefit from earlier or more accurate cancer detection through new biomarkers.
How similar studies have gone: Other biomarker discovery efforts have shown promise when standardized collaboration and data sharing are implemented.
Where this research is happening
-
Arizona State University-Tempe Campus
Scottsdale, United States Active
Researchers
- Principal investigator: Labaer, Joshua — Arizona State University-Tempe Campus
- Study coordinator: Labaer, Joshua
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.